Solventum Corporation (SOLV)
After hours:
| Previous close | 51.60 |
| Open | 51.63 |
| Bid | 0.00 x 900 |
| Ask | 0.00 x 800 |
| Day's range | 50.61 - 51.77 |
| 52-week range | 50.49 - 72.40 |
| Volume | |
| Avg. volume | 2,027,200 |
| Market cap | 8.782B |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | 13.82 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- PR Newswire
U.S. News & World Report Expands Use of Solventum's Ambulatory Potentially Preventable Complications Grouping Software for Use in Its 2024-2025 Best Hospitals Rankings
Solventum today announced that U.S. News & World Report is expanding its use of Solventum's 3M™ Ambulatory Potentially Preventable Complications (AM-PPCs) software in the analysis of its 2024-2025 Best Hospitals rankings.
- PR Newswire
Solventum introduces denials prevention solution, an AI-powered tool, empowering health systems to help reduce write-offs and improve top line revenue
Solventum (NYSE: SOLV), [formerly 3M Health Care] today announced a new artificial intelligence (AI)-driven payment integrity and revenue cycle solution, Solventum™ Revenue Integrity System. In collaboration with Sift Healthcare, this solution is designed to help health systems not only reduce potential denials but prevent them and ensure timely and accurate payer reimbursement.
- PR Newswire
Solventum Cautions Investors Regarding TRC Capital's "Mini-Tender Offer"
Solventum (NYSE: SOLV) has been notified that TRC Capital Investment Corporation ("TRC") made an unsolicited "mini-tender offer" to purchase up to 2,000,000 shares of the company's common stock at $59.15 per share and decreased the offer price on June 6, 2024, to $55.00 per share. The closing stock price of Solventum's common stock on June 6, 2024 was $55.05.
